Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be able to travel to the Florida Atlantic University Clinical Research Unit, speak verbally, and be able to walk.
- You must be between 65 and 80 years old (inclusive).
- If you have Alzheimer's disease, you must have a formal diagnosis from your doctor based on clinical assessment AND either a positive amyloid PET scan or a positive FDA-approved test from cerebrospinal fluid or blood.
Who may not be able to join:
- People younger than 65 or older than 80 years of age.
- People whose dementia is severe enough that they would need sedation to have an MRI scan.
- People currently receiving the intravenous anti-amyloid treatments Leqembi or Kinsula.
- People who have a pacemaker or any other device or implant in their body that is not safe to use with an MRI machine (for example, anything containing metal parts).
- People who have a history of seizures (epilepsy or similar conditions).
- People who work night shifts.
- People who currently have cancer, or who have been diagnosed with cancer in the last 5 years (certain minor skin cancers may be excluded from this rule — confirm with trial site).
- If you do not have Alzheimer's disease, you may not be eligible if you score below 26 on a standard memory and thinking test called the MoCA.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Corinne Lasmezas, PhD, Florida Atlantic University
Phone: 561-235-4467
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Brain NAD
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.